Cargando…

EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis

BACKGROUND: Our goal was to investigate the prevalence of the epidermal growth factor receptor (EGFR) mutation in Middle East and African countries and to compare its prevalence with that shown in other populations. METHODS: We used PubMed and the Cochrane Library databases to conduct a literature s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benbrahim, Zineb, Antonia, Teresita, Mellas, Nawfel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137870/ https://www.ncbi.nlm.nih.gov/pubmed/30217176 http://dx.doi.org/10.1186/s12885-018-4774-y

Ejemplares similares

Colorectal cancer: new developments after the 2013 ECCO/ESMO congress
por: Mellas, Nawfel, et al.
Publicado: (2014)

La dégénérescence cérébelleuse paranéoplasique révélant une récidive métastatique du cancer d’ovaire
por: Zouiten, Othmane, et al.
Publicado: (2019)

Heterogeneous distribution of EGFR mutation in NSCLC: Case report
por: Boukansa, Sara, et al.
Publicado: (2023)

Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
por: Oualla, Karima, et al.
Publicado: (2020)

How Is Morocco Reacting to COVID-19 Crisis in Anticancer Centers?
por: Oualla, Karima, et al.
Publicado: (2020)

Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker
por: Oualla, Karima, et al.
Publicado: (2021)

Maxillofacial metastasis from breast cancer
por: Namad, Tariq, et al.
Publicado: (2014)

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

Prevalence and Patterns of EGFR Mutations in Non-small Cell Lung Cancer in the Middle East and North Africa
por: Boustany, Youssra, et al.
Publicado: (2022)

Askin’s tumor: a case report and literature review
por: Benbrahim, Zineb, et al.
Publicado: (2013)

Mésothéliome malin de l´ovaire: à propos d´un cas
por: Ouafki, Imane, et al.
Publicado: (2021)

A primary mediastinal germ cell tumor of yolk sac type: case report
por: Darif, Khadija, et al.
Publicado: (2021)

Psychological Distress, Coping Strategies, and Quality of Life in Breast Cancer Patients Under Neoadjuvant Therapy: Protocol of a Systematic Review
por: Omari, Majid, et al.
Publicado: (2022)

Quasi-Complete Response of Classic Kaposi's Sarcoma Treated with Weekly Paclitaxel
por: Benbrahim, Zineb, et al.
Publicado: (2013)

Para testicular rhabdomyosarcoma in adults: three case reports and review of literature
por: Boudahna, Lamiae, et al.
Publicado: (2014)

Dermatomyosite et cancer rectal: à propos d’un cas avec revue de la littérature
por: Ouahbi, Hajar, et al.
Publicado: (2019)

Giant metastasis of the thenar eminence revealing ovarian rhabdomyosarcoma
por: Oualla, Karima, et al.
Publicado: (2020)

Pulmonary benign metastasizing leiomyoma
por: Amaadour, Lamiae, et al.
Publicado: (2021)

Prevalence and Risk Factors of Burnout Among Female Oncologists From the Middle East and North Africa
por: Abusanad, Atlal, et al.
Publicado: (2022)

Validation of Mini-Mental Adjustment to Cancer scale in a Moroccan sample of breast cancer women
por: Ragala, Mohammed El Amine, et al.
Publicado: (2021)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012)

EGFR ‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
por: Phan, Thang Thanh, et al.
Publicado: (2021)

A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
por: Cui, Ran, et al.
Publicado: (2022)

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity
por: Chougule, Anuradha, et al.
Publicado: (2013)

The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy
por: Demiray, A, et al.
Publicado: (2018)

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY
por: Nishio, Makoto, et al.
Publicado: (2020)

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Yue-Lun, et al.
Publicado: (2016)

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib
por: Buder, Anna, et al.
Publicado: (2020)

Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
por: Pereira, Isabel, et al.
Publicado: (2020)

Role of chemotherapy in the management of primary rectal lymphoma: a case report and review of the literature
por: Ismaili, Nabil, et al.
Publicado: (2009)

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
por: Tufman, Amanda, et al.
Publicado: (2017)

The Frequency of Epidermal Growth Factor Receptor (EGFR) mutations in Iraqi patients with Non-Small Cell Lung Cancer (NSCLC)
por: Ramadhan, Hanan H, et al.
Publicado: (2021)

Primary neuroendocrine tumors of the breast: two case reports and review of the literature
por: Hejjane, Loubna, et al.
Publicado: (2020)

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
por: Brcic, Luka, et al.
Publicado: (2016)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis
por: Buonerba, Carlo, et al.
Publicado: (2019)

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
por: Matsuo, Norikazu, et al.
Publicado: (2016)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
por: Hsu, Kuo-Hsuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fnqh3ka1j7ifmkekhtbqearcid